| __timestamp | Bristol-Myers Squibb Company | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 25669000 |
| Thursday, January 1, 2015 | 12651000000 | 48925000 |
| Friday, January 1, 2016 | 14481000000 | 79263000 |
| Sunday, January 1, 2017 | 14710000000 | 155647000 |
| Monday, January 1, 2018 | 16014000000 | 246032000 |
| Tuesday, January 1, 2019 | 18067000000 | 300982000 |
| Wednesday, January 1, 2020 | 30745000000 | 348292000 |
| Friday, January 1, 2021 | 36445000000 | 360697000 |
| Saturday, January 1, 2022 | 36022000000 | 396473000 |
| Sunday, January 1, 2023 | 34313000000 | 475894000 |
| Monday, January 1, 2024 | 36351000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding financial health is crucial. This analysis delves into the gross profit trends of Bristol-Myers Squibb Company and Corcept Therapeutics Incorporated from 2014 to 2023. Over this period, Bristol-Myers Squibb demonstrated a robust growth trajectory, with its gross profit peaking in 2021 at approximately 36 billion, marking a 204% increase from 2014. In contrast, Corcept Therapeutics, while smaller in scale, showed a remarkable growth rate, with its gross profit surging by over 1,750% from 2014 to 2023, reaching nearly 476 million. This stark contrast highlights the diverse strategies and market positions of these two companies. As Bristol-Myers Squibb capitalizes on its expansive portfolio, Corcept Therapeutics continues to carve its niche in the market, showcasing the dynamic nature of the pharmaceutical sector.
Gross Profit Comparison: AstraZeneca PLC and Corcept Therapeutics Incorporated Trends
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Halozyme Therapeutics, Inc.
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: Exelixis, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Corcept Therapeutics Incorporated vs Veracyte, Inc.
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs MorphoSys AG
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Vericel Corporation